The aging brain frequently harbors multiple protein pathologies that contribute to Alzheimer's, Parkinson's and other neurodegenerative diseases. But how do these problematic proteins interact with each other, and could these interactions inform future therapies? Researchers at TGen, part of City of Hope, are answering some of these questions with the help of a unique mouse model that combines different mixtures…
Source: Medical Xpress
